Reprogramming of human γδ T cells by expression of an anti-CD19 TCR fusion construct (εTRuC) to enhance tumor killing

In conclusion, the generation and use of γδ εTRuC T cells might be a new approach for cancer immunotherapy.PMID:38149982 | DOI:10.1093/jleuko/qiad128
Source: Journal of Leukocyte Biology - Category: Hematology Authors: Source Type: research